Generic Zocor Prompts Some Part D Plans To Make Formulary Adjustments
Executive Summary
The largest Medicare Part D sponsors are taking a variety of approaches to Zocor's formulary position following the introduction of a generic version of simvastatin, but they are not going to some of the extremes that non-Medicare commercial plans are
You may also be interested in...
Lipitor Pricing Offsets Loss In Prescription Volume, Pfizer Says
Declines in Lipitor's prescription volume due to the presence of generic simvastatin are being offset by price increases, Pfizer says
Lipitor Pricing Offsets Loss In Prescription Volume, Pfizer Says
Declines in Lipitor's prescription volume due to the presence of generic simvastatin are being offset by price increases, Pfizer says
Zoloft To Be Dropped From WellPoint, Medco Part D Formularies
WellPoint and Medco are planning to remove Pfizer's Zoloft from their Part D formularies once a generic version of the antidepressant becomes available, according to the companies. The drug's patent expired on June 30 and FDA announced its approval of a generic the same day